SAN DIEGO, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE, founded in 2009, is a community nonprofit in the Diseases & Disorders sector that reported $6.8M in total revenue in fiscal year 2023.
Proteogenomics Research Institute for Systems Medicine (PRISM) is a non-profit biomedical research institute focused on the development of innovative treatments for a wide spectrum of human diseases, including cancer.
PRISM is focused on the development of innovative treatments for a wide spectrum of human diseases, including cancer. PRISM employs the principles of systems science, an ordered and interdisciplinary...
PRISM is focused on the development of innovative treatments for a wide spectrum of human diseases, including cancer. PRISM employs the principles of systems science, an ordered and interdisciplinary approach to study the relationships between healthy and diseased tissues. PRISM's state-of-the-art facilities combine advanced technologies in proteomics, genomics and in vivo imaging to discover and validate novel therapeutic targets. PRISM develops novel molecules and probes which allow dynamic, non-invasive functional imaging of healthy and diseased tissue in vivo. These molecules and probes are the core component of new therapies, which specifically target diseased organs while sparing normal tissues and cells. In this way, PRISM is developing more effective, less toxic treatments that extend life and provide a better quality of life for patients diagnosed with chronic and life-threatening diseases.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $6,841,348 | $6,644,651 | +0.0% |
| Expenses | $6,671,889 | $6,669,615 | +0.0% |
| Net Income | $169,459 | $-24,964 | -7.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JAN E SCHNITZER MD | President & CEO | 40.00 |
Officer
Director
|
$211,593 | $93,856 | $305,449 |
| MICHAEL LEVIN | DIR NANOTECHNOLOGY | 40.00 |
|
$132,212 | $39,206 | $171,418 |
| ADRIAN CHRASTINA | ASST. PROFESSOR | 40.00 |
|
$128,904 | $37,607 | $166,511 |
| BOGDAN OLENYUK | PROFESSOR | 40.00 |
|
$135,685 | $25,083 | $160,768 |
| TIMOTHY BUSS | SR RESEARCH SCIENT | 40.00 |
|
$128,747 | $24,554 | $153,301 |
| L JEAN REMMER | Vice President | 32.00 |
Officer
Director
|
$136,555 | $15,431 | $151,986 |
| Ann FENNELLY | DIR OF FINANCES | 32.00 |
|
$99,708 | $12,354 | $112,062 |
| JOHN ROUSSIN | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| EVE DREYFUS MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $6,841,348 | $6,671,889 | $1,090,137 | $169,459 |
| 2023 | $6,644,651 | $6,669,615 | $1,762,990 | $-24,964 |
| 2022 | $6,513,962 | $6,514,913 | $604,813 | $-951 |
| 2021 | $6,338,425 | $6,338,551 | $645,330 | $-126 |
| 2020 | $5,972,491 | $5,923,172 | $567,623 | $49,319 |
| 2019 | $4,758,695 | $4,759,622 | $480,689 | $-927 |
| 2018 | $4,950,379 | $4,953,016 | $504,887 | $-2,637 |
Compare PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE with other nonprofits in California and across the country.